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ScienceDirectAt least 46 interactome studies, broad at proteome scale or
biologically more focused, have together mapped about 75,000
human protein–protein interactions (PPIs). Many of the studies
addressed local interactome data paucity analyzing specific
homeostatic and regulatory systems, with recent focus
demonstrating the involvement of post-translational protein
modification (PTM) enzyme families in a wide range of cellular
functions. These datasets provided insight into binding
mechanisms, the dynamic modularity of complexes or
delineated combinatorial enzymatic cascades. Furthermore,
the combined study of PPI and PTM dynamics has begun to
reveal conditional rewiring of molecular networks through PTM-
mediated recognition events. Taken together these studies
highlight the utility of local and global interaction networks to
functionally prioritize the many changing PTMs mapped in
human cells.
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Most cellular functions are in large part driven by the
coordinated action of multiple macro-molecular assem-
blies of interacting protein subunits. Defining the mol-
ecular architecture of how these individual protein
building blocks interact is a major task fundamental to
a better understanding of cellular processes in health and
disease [1,2]. Both broad and focused protein–protein
interaction (PPI) studies have recently dented interac-
tome data paucity and provided novel insight into a
diverse array of cellular systems. Yet, the mapping of
conditional interactions, that is, interactions that are
strengthened or loosened under specific conditions and
thus change with changing conditions, has just started [3].
Here, we collect recent systematically generated human
interaction data: focused studies that lead to functional or
mechanistic insights as well as broad, proteome wide PPICurrent Opinion in Structural Biology 2014, 24:34–44 data resources. We further point out that interaction
approaches are particularly useful in understanding of
post-translational modification (PTM)-mediated sig-
naling, both in defining modifying enzyme relationships
and in delineating PTM-dependent, conditional inter-
actions. Finally, we highlight how collated interactome
data can be used in conjugation with PTM data to extract
biological signals from PTM collections and drive insight
into PTM signaling.
Recent progress in systematic human PPI
mapping
Generating datasets broad in scope is fundamental to
interactome mapping, providing an increasingly better
framework for further analysis. Much of the work to
improve data quality focused on determining and improv-
ing the specificity of large scale PPI approaches [4–6].
Given high specificity, it is relatively low coverage large
unbiased data sets suffer from. Comprehensive interac-
tome mapping requires both search space and interaction
coverage: that is, methods that scale well with the number
of protein pairs/complexes to be assayed and high sensi-
tivity of the methods to actually detect the interactions in
the search space. As such methods have substantially
improved. For example Y2H approaches have seen sec-
ond generation sequencing techniques utilized to reduce
work load and increase sensitivity in large data set gener-
ation [7,8]. Two mass spectrometry (MS) based
approaches extensively fractionated human culture cells
to infer interaction relationships from the obtained co-
fractionation patterns [9,10]. Affinity purification of cell
cycle related proteins [11] and protein complexes immu-
noprecipitated using 1800 antibodies targeted against
more than 1000 transcription co-regulatory proteins [12]
lead to additional substantial human interactome data
sets (Table 1). Also, luminescence based co-IP methods,
originally coined LUMIER, have been further exploited
as a stringent pair wise PPI screening system
[13,14,15]. Ultimately, high coverage data will result
from combining interactomes generated with different
approaches. For example in yeast two-hybrid (Y2H)
analyses, weaker, more transient interactions can be
better sampled [16] because interactions are measured
out of a binding equilibrium via transcriptional reporter
activity, and not the physical interacting proteins as such.
Therefore Y2H data contain, for example, a larger fraction
of signaling interactions while more cooperative associ-
ations in processes like transcription and protein homeo-







































Large human protein–protein interaction data sets. Table summarizes data sets generated in a systematic, well controlled way. Studies are described by listing first author + year,
ENTREZ pub med identifier, the topic of the study, number of baits, number of preys(in binary approaches) or the search space, the number of PPIs, main PPI screening method and
the reference. Single protein data sets have not been included even though they report many, sometimes hundreds, of interactions. Further, significant data sets have been published
describing interactions from organisms such as E. coli, yeast, C. elegans, Drosophila or Arabidopsis which are not considered here.
Study PMID Topic Baits Preys/space PPIsb Methods Refs
Malovannaya, 2011 21620140 ‘Co-Regulation’;
transcriptional and signaling
proteins
1088 HeLa S3 cells 14443 (top 5%of [74]) IP of endogenous prots with 1796
Abs::MS
[12,74]
Havugimana, 2012 22939629 Cofractionation of a human
cell line
HeLa S3 and HEK293 HeLa S3 and HEK293 cells 14168 Cofractionation::MS [9]
Kristensen, 2012 22863883 Size exclusion
chromatography of a human
cell line
HeLa (+/EGF) HeLa S3 cells (+/EGF) 7173 (=291
complexes)
Cofractionation (PCP-SILAC)::MS [10]
Ewing, 2007 17353931 Selected annotated proteins 338 HEK293 cells 5807 FLAG-tag::MS; transient
transfection
[75]
Wang, 2011 21988832 Liver PPIs 4788/1428 4740/liver cDNA library 3484 Y2H [76]
Bell, 2009 19293945 Aging processes 175 cDNA librariesa 3229 Y2H [73]
Stelzl, 2005 16169070 1st systematic human Y2H
matrix screen
4456 5632 3184 Y2H [77]
Rual, 2005 16189514 1st systematic human Y2H
matrix screen
7263 7263 2754 Y2H [78]
Mukherji, 2007 17001007 Human cell-cycle regulators 459 cDNA librariesa 2631 Y2H with RNAi [79]
Vinayagam, 2011 21900206 Directed signaling network
(EGF-signaling)
473 7800 2623 Y2H [39]
Bandyopadhyay, 2010 20936779 MAPK singaling 81 cDNA librariesa 2268 Y2H [38]
Hutchins, 2010 20360068 Mitosis 239 HeLa S3 cells 1923 GFP-tag::MS; expression from BAC
clones
[11]
Yu, 2011 21516116 Stitch-seq approach 6000 6000 1166 Y2H (stitch-seq) [8]
Sowa, 2009 19615732 DUBs 75 HEK293T cells 1048 GFP-tag::MS; from stable cell lines [51]





Miller, 2009 19888210 Wnt signaling 640 11 812 Lumier with RNAi, cDNA
overexpression
[14]
Jeronimo, 2007 17643375 Transcription and RNA
Processing
32 EcR-293 cells 781 TAP-tag::MS; from stable cell lines [80]
Lim, 2006 16713569 Ataxias 54 7263 + brain cDNA library 770 Y2H [81]
Ravasi, 2010 20211142 Transcription factor —
transcription factor, (M.m. &
H.s.)
1222 1222 762 Mammalian-2H [82]
Behrends, 2010 20562859 Autophagy 65 HEK293T cells 709 FLAG-HA-tag::MS; retroviral
expression lines
[83]
Colland, 2004 15231748 Smad pathway 44 Placental cDNA library 706 Y2H [84]
Hegele, 2012 22365833 Spliceosome 237 237 632 Y2H with Lumier [26]
Markson, 2009 19549727 E2–E3 RING 39 153 568 Y2H (matrix + library) [43]
Weimann, 2013 23455924 Protein methyltransferases
and demethylases
22 13000 522 Y2H (Y2H-seq), with Lumier [7]
Varjosalo, 2013 23602568 CMGC group kinases 57 HEK293 TREX cells 511 SH-tag::MS; from stable cell lines [35]
Sardiu, 2008 18218781 TIP49 centered complexes 27 HEK293 cells 485 (probabilistic
network)



































































Table 1 (Continued )
Study PMID Topic Baits Preys/space PPIsb Methods Refs
Varjosalo, 2013 23455922 Selected kinases of different
kinase families
32 HEK293 TREX cells 485 SH-tag::MS; from stable cell lines [6]
Bennett, 2010 21145461 Cullins 11 HEK293T cells 460 FLAG-HA-tag::MS; from stable cell
lines
[49]
Taipale, 2012 22939624 HSP90 client interactions:
kinases, E3s, TFs
1414 2 393 Lumier [15]
Joshi, 2013 23752268 HDACs 11 CEM T-cell lines 387 EGFP-FLAG-tag::MS; from stable
cell lines
[40]
Perez-Hernandez, 2013 23463506 Tetraspanins 8 Lysates or exome extracts of
prim. Lymphoblasts
359 (240 + 172) Pulldowns with intra cellular
peptides::MS from T cells or exome
preparations
[27]
van Wijk, 2009 19690564 E2-E3(RING) 35 250 304 Y2H [44]
Albers, 2005 15604093 NR interacting proteins Y2H 38 cDNA libraries 290 Y2H [86]
Goudreault, 2009 18782753 PP2A complex 21 HEK293 cells 268 TAP or FLAG-tag::MS; from stable
cell lines
[37]
Venkatesan, 2009 19060904 Empirical quality assessment
of HTP-PPI data
1744 1796 239 Y2H [4]
Woodsmith, 2012 22493164 E3(RING)-E3(RING) 119 123 228 Y2H [47]
Bouwmeester, 2004 14743216 TNF-alpha/NF-kappa B
signaling
32 HEK293 cells 200 TAP-tag::MS; from stable cell lines [87]
Soler-Lopez, 2011 21163940 Alzheimer’s disease 18 74 200 Y2H (matrix + library) [88]
Wang, 2008 18624398 Ras-MAPK/PI3K pathways 42 cDNA library 200 Y2H [89]
Camargo, 2007 17043677 DISC1 (Disrupted in
Schizophrenia) interactome
9 cDNA library 188 Y2H [90]
Glatter, 2009 19156129 PP2A complex 11 HEK293 cells 188 SH-tag::MS; from stable cell lines [36]
Ellis, 2012 22749401 Splice variant specific PPIs 173 46 172 Lumier [13]
Gao, 2012 22325352 PRC1 Family Complexes 15 HEK293 cells 170 FLAG-HA-tag::MS; from stable cell
lines with CHIP-seq
[48]
Goehler, 2004 15383276 Huntington’s Disease 51 cDNA library 164 Y2H (matrix + library) [91]
Brehme, 2009 19380743 BCR-ABL complex 10 K562 CML cell line 157 (8 core network) TAP-tag::MS; retroviral expression
lines (BCR-ABL IP with Abs)
[32]
Wallach, 2013 23555304 Circadian clock 46 46 150 Y2H with RNAi [92]
a Using results from the Prolexys human protein interaction network; 345,000 individual yeast two-hybrid library screens that resulted a filtered core network with 70,358 unique binary interactions
between protein fragments representing 10,425 unique genes curated as NCBI RefSeq entries [73].




















































Human protein interaction networks Woodsmith and Stelzl 37PPI data sets must carefully be quality controlled either
empirically [4,17], through benchmarking [18] or, for the
folded part of the proteome, assessed through structural
modeling [19,20]. Computational scoring of PPIs, for
example, using network properties [21,22], can be very
useful for high quality network construction, however the
method of choice strongly depends on the biological
questions asked. PPI detection methods, PPI quality
measures, scoring and PPI databases have been subject
of comprehensive recent reviews including Refs.
[17,18,20]. Please refer to Table 1 for a summary of recent
large-scale human interactome mapping studies.
These interaction datasets, along with other recent well
controlled high throughput (HTP) studies, are invaluable
for their unbiased approach. They collectively fuel
advanced integrative approaches, ‘big data’ modeling
and clinical data interpretation [23,24]. On the cellular
systems level, they are fundamental to the interpretation
of genetic and protein variation and can lead to mechan-
istic insight (Figure 1a). For example, Lee et al. recently
derived the likely mis-location of >150 proteins in glioma
from a combination of PPIs, expression data and bio-
chemical protein features [25]. This analysis derived how
ectopic network structure, driven by alterations in gene
expression profiles, can lead to alteration of protein local-
ization, and by proxy altered protein function in disease.
In isolation however, precisely this global interactome
approach can predicate detailed mechanistic understand-
ing of specific systems, as global mapping more or less
randomly samples a subset of the interactions from large
search spaces at relatively low coverage. It is difficult to
answer specific mechanistic questions with sparse and
somewhat technically biased data, rather the value is the
high quality data resource as such and biological insight is
given in form of novel global analyses, statistical trends,
testable hypotheses and unexpected leads. Biologically
focused screens sample a smaller number of potential
interactions much more thoroughly, providing high cover-
age data to enable a better dynamic and mechanistic view
of specific cellular processes or protein assemblies. High
coverage interaction mapping among the components of
relatively well defined molecular systems, for example,
the spliceosome [26], can shed new light on the potential
subunit interplay and here led to unforeseen mechanistic
details with regards to the dynamics of sub-complex
rearrangement in the course of spliceosome assembly
and intron excision. Conversely, the potential functional
repertoire of less well characterized groups of proteins,
such as tetraspanins [27] or tandem-BRCT domain
proteins [28], are more consistently defined through
focused interactome mapping approaches.
Characterizing the PTM modifying enzyme
interaction space
Many of the recent PPI sets focused on modifying
enzymes, that is, kinases, phosphatases, methyltransferases,www.sciencedirect.com deacetylases, and E2/E3 ubiquitin ligases (Table 1). PTM
systems, as defined through writer/reader/eraser/substrate
components [29], are requisite for cellular functioning.
Ectopic expression or activity can cause a wide variety of
human diseases, reflected in the number of pharmaceuticals
targeted at PTM components currently in clinical trials [30].
Despite this, the vast majority of research has been restricted
to just a small fraction of PTM components such as the
‘hottest’ 50 kinases [31], highlighting the need for more
systematic approaches. Also, more than 100,000 PTMs
contrast the relatively small number of enzymes that med-
iate modification and leave the substrate–enzyme relation-
ships largely elusive. In addition, interactions involving
PTM-enzymes are thought to be relatively weak and tran-
sient thus suffer from poor coverage in the current global
interactome data. Several recent interactome studies focus-
ing on PTM-enzymes have been conducted using distinct
methodological approaches and provided context for orphan
or poorly annotated nodes in PTM networks, highlighting
hitherto unknown functions controlled by PTM systems
(Figure 1B(i)).
Many studies have tackled interactomes of disease
relevant single kinases such as BCR-ABL [32,33] or
LRRK2 [34]. Providing a more global context for kinase
function, two recent studies by Varjosalo et al. presented
proteomic analysis of complexes of a large number of
human CMGC kinases [35] and of selected kinases from
other major families [6]. 481 and 345 co-complex mem-
bers were identified for 57 and 32 kinases (512 and 488
PPIs) via LC–MS/MS, in the two studies respectively.
Not surprisingly, interaction partners of the different
kinases point towards their involvement in many differ-
ent cellular processes. Only the most closely related
kinases show significant overlapping interaction pattern
and no kinase family trends are apparent, suggesting
largely non-redundant functions for the enzymes.
Together with global phospho-site information these data
provide a basis for the inference of kinase-substrate net-
works as suggested for SRPK1 and SRPK2 and their
spliceosomal substrates [35].
AP-MS approaches were further utilized to assess the mod-
ular composition of the human phosphatase PP2A complex
through affinity purification of the individual subunits
[36,37]. Covering the complexes in extensive reciprocal
purifications, the two studies observe pronounced modular-
ity of the holo-PP2A complexes including, for example, a
Striatin, STRIP1/2, CTTNBP2NL, MST4 containing
module.
Two large Y2H studies [38,39] included mitogen acti-
vated protein kinases (MAPKs) and MAPK signaling
proteins providing quite complementary analyses of
the large signaling PPI data sets obtained (including
716 and 584 kinase PPIs, respectively). Bandyopadhyay
et al. [38] probed MAPK-mediated signaling throughCurrent Opinion in Structural Biology 2014, 24:34–44
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Interactome mapping strategies. (a) Collated PPI data as a framework for integrative network biology. Integration of proteome wide PPI datasets with
independent protein/gene annotations uncovers emergent properties of cellular systems. (b) Strategies for addressing local PPI data paucity. (i)
Increasing PPI coverage of poorly studied proteins. (ii) High density PPI mapping within defined protein–protein interaction types or known molecular
complexes. (iii) Hierarchical cascade delineation through high density PPI mapping of specific interaction sub-types. (iv) Elucidation of interactions
which are dependent on, or mediated by, specific PTMs or residues in response to a signal.
Current Opinion in Structural Biology 2014, 24:34–44 www.sciencedirect.com
Human protein interaction networks Woodsmith and Stelzl 39RNAi knockdowns of 45 MAPK-interacting proteins.
Vinayagam et al. [39] used overexpression perturbation
analysis of 50 proteins in the network to assess the
directionality of signal flow through the large network.
Though all these kinase/phosphatase interactome stu-
dies elaborate on very different aspects in their data
analyses, they commonly broaden our view of phos-
phorylation  function in the cell (Figure 1B(i)).
Similarly, less intensively studied PTM systems have also
received recent attention. Affinity purifications from cul-
tured T-cells [40] provided binding profiles for all 11
cytoplasmic and nuclear ‘histone’ deacetylase proteins
(HDACs). Protein methylation related enzymes were
investigated in an analogous approach using a novel
Y2H methodology to define sets of putative methylation
targets and regulators for 22 protein methyltransferases
and demethylases [7]. Both of these studies highlighted
the underappreciated functions for these PTMs outside
of their canonical role in epigenetic regulation of tran-
scription, with many interactors [7] or the enzymes
themselves [40] residing outside of the nucleus. These
and other studies (Table 1) provide direct systematic
evidence for alternate, cytoplasmic PTM functions
through observed interaction profiles, significantly
extending anecdotal evidence collected from a handful
of small scale studies.
Many kinases are known to require the chaperone
HSP90, a quality control system of protein folding, for
activity. Through study of HSP90 interactions with 314
kinases, using a modified LUMIER system, Taipale et al.
[15] could begin to unravel global principles of protein
client recognition (Figure 1B(ii)). Interestingly they
could rule out simple explanations of single amino acid
determinants of binding, instead providing evidence that
HSP90 could distinguish clients from none clients based
on intrinsic protein stability. This applied kinome wide
and could discriminate between highly homologous
kinases such as ARAF and BRAF.
PTM systems such as phosphorylation operate using a
direct enzyme–substrate mechanism, however the ubi-
quitin and ubiquitin-like families of enzymes represent a
key challenge in network biology as they operate in a
combinatorial, hierarchical enzymatic cascade [41,42].
The pairwise permutations of 40 E2 conjugating
enzymes with >300 E3 ligases, in combination with
specific partner preferences within E3 ligase multimers,
together control the target and architecture of ubiquitin
modification, and are thus crucial to understanding regu-
lation in ubiquitin biology (Figure 1B(iii)). Three distinct
Y2H studies tackled the 12,000 putative E3 RING
ligase interactions with their cognate E2 conjugation
enzymes [43–45], highlighting the utility in using
multiple Y2H experimental set-ups to address interaction
space coverage. These papers revealed similar patterns ofwww.sciencedirect.com E2 binding with several E2s (UBE2Ds/Es/W and N)
appearing to operate as ubiquitination work horses, enga-
ging in many interactions with a wide variety of E3
RINGs. Conversely, some E3s are highly selective, inter-
acting with one or few E2 enzymes (e.g. ARIH1-
UBE2L3/6, MARCH10-UBE2N/K). These and litera-
ture studies now present a biophysical framework of
approximately 1000 E2–E3 RING interactions, allowing
both systematic trends and reductionist hypotheses to be
tested across the entire E3 RING family. In this branch of
the ubiquitin cascade further regulatory potential is
achieved through E3 RING homo-dimerisation and het-
ero-dimerisation, highlighted through structural analysis
of the BARD1-BRCA1 disease related heterodimer [46].
A systematic Y2H analysis revealed these interactions
highly prevalent, especially through the large TRIM sub-
family and PCGF proteins [47]. Concomitantly, AP-MS
and CHIP-seq experiments revealed alternate PCGF-
RNF2 heterodimerisations recruit RNF2 to different
genomic loci in distinct protein complexes [48], as such
suggesting RING dimerisation could extend the canoni-
cal linear cascade to facilitate ubiquitination of alternate
substrate proteins in trans [47].
A second large branch of E3 ligases is represented by
the multi-subunit cullin complexes. Bennett et al. [49]
used systematic AP-MS to highlight individual cullin
complex composition in human cultured cells,
suggesting a substrate adaptor model for cullin E3 ligase
regulation. Furthermore, interaction partners defined a
plethora of roles for well-studied de-ubiquitinases
(DUBs) in processes such as the COP9 signalsome
[50] and the proteosome, together with initial insight




As addressed above, mapping of interaction profiles for
enzymes and regulators involved in PTM signaling has
accelerated in recent years, revealing multiple novel
aspects of PTM regulated biology. One functional
PTM paradigm provided by small scale studies is their
ability to dynamically alter interaction partner prefer-
ences in response to stimuli. These conditional inter-
actions can either be mediated through single
modification events, or through multiple modifications
in short sequence space.
In general, recognition of PTMs is often mediated
through specialized domains in dedicated families of
modular proteins [29], with most interaction knowledge
stemming from assaying these domains with short modi-
fied peptides. Recently, Src homology 2 domains (SH2),
known to bind phospho-tyrosine residues, were tested for
interactions on peptide arrays containing phospho-pep-
tides that resemble known in vivo phospho-sites [52,53].Current Opinion in Structural Biology 2014, 24:34–44
40 Folding and bindingIn the context of a neuronal network prediction frame-
work these data provided a wealth of new potential
conditional interactions [52]. Furthermore, remarkable
interaction specificity was seen in SILAC based quanti-
tative pull-downs that captured cellular binding partners
with methylated histone-derived peptides [54,55].
Finally, general principles of multi-site PTM recognition
could be experimentally observed between structurally
characterized BROMO domains and multiply-modified
histone tail peptides [56].
However, studies turn more towards models/approaches
which better resemble the context of the interactions in a
cell using full length proteins. For example, SRM-based
interaction quantification from affinity purifications of the
adapter protein GRB2 was used in combination with
domain mutations and short interfering RNA knockdown
probes to interrogate the conditional GRB2 interactome.
Bisson et al. [57] separated direct from indirect, and SH3-
domain from SH2-domain mediated (i.e. phosphoryl-
ation-dependent), interactions within a group of 90
GRB2 complex members in response to distinct stimuli.
Another approach used the Polo-box domain of polo-like
Kinase 1, a domain that preferentially binds phospho-
proteins, to purify 622 proteins from cell cycle arrested
osteosarcoma U2OS cell lysates which were co-enriched
for the optimal PLK phospho-binding and PLK1 phos-
phorylation-site motifs [58].
These affinity purification studies reveal mostly correla-
tive information about PTM-dependent complex formation,
with either the modification-site or the recognition site
known and both direct or indirect relationships have
explanatory potential (Table 2). A deeper mechanistic
understanding implies knowledge about PTM-mediated
interactions, where both the modified site and the corre-
sponding recognition site are known. Recent mediumTable 2
PTM-dependent and PTM-mediated interactions. Examples illustrati
influenced by PTMs.
Principle of indirect PTM effect Example mec




Allosteric conformational change Phosphorylatio
conformation





PTM mediated Single phospho-Y residue SH2 
Multiple methyl-R residues TUDOR 
Polyubiquitin chain UBAN-ZF 
Current Opinion in Structural Biology 2014, 24:34–44 scale studies have begun to address these complexities
using selective reaction monitoring (SRM) based MS
techniques to investigate PTM-mediated interactome
alterations (Figure 1B(iv)). In an integrated approach,
using a combination of peptide array, bioinformatic
analysis and SRM based MS analysis, Liu et al. [59]
identified 40 lysine methylation sites across 28 proteins
that associated with the chromo domain containing het-
erochromatin binding protein HP1b. They then high-
lighted the functional relevance of DNA-PKcs
methylation mediated HP1b interaction in the DNA
damage response [59]. Elucidating both PTM-depend-
ent and PTM-mediated complex formation, Zheng et al.
[60] recently tracked the relative abundance of a subset
of 41 SHC1 interacting proteins during EGF stimulation
and correlated these with both early pY and later pS/T
modifications. A phospho-Y313-mediated, proliferative
Grb2-dependent cluster of proteins bound 1–3 min after
EGF treatment. At 3–9 min, the SHC1-S29 Akt-phospho-
site resulting from this activation starts the signal termin-
ation, that is, recruitment of a distinct set of proteins
including Ptpn12, a tyrosine phosphatase displacing
SHC1 from the receptor. During the late response
SHC1 somehow recruits proteins involved in cytoskeletal
dynamics that cluster with phosphorylation of SHC1-
T147 and S335. Although the late phospho-dependent
signal flow is not understood these phospho-sites are
crucial for restricting proliferation. Formation of this
signaling complex depends on the PTMs, therefore the
interaction isolation through IP provided the necessary
enrichment to correlate the dynamics of multiple inter-
acting species simultaneously with the dynamics of SHC1
phosphorylation in EGF-signaling [60].
The literature provides excellent examples of studies
starting to elucidate phosphorylation-dependent sig-
naling networks in detail and first network approachesng potential mechanisms for interactions/co-complex formation
hanism Specific interaction Ref
 leads to nuclear HDAC3 increased binding to HDAC5
upon nuclear retention
[93]
n regulates protein Phosphorylation of S518 in NF2
(merlin) regulates its conformation;





Upon IGF treatment, GRB2 binds
PIK3 subunits in an IRS4 dependent
manner
[57]
gnition domain Specific interaction Ref





Human protein interaction networks Woodsmith and Stelzl 41addressing the recognition of other PTMs, such as K-
acetylation or K/R-methylation are also under way. How-
ever, systematic studies that assess the potential of Ub
and Ub-like dependent interactions in signaling are elu-
sive. 20 families of Ub binding proteins with the potential
to recognize non-degradation triggering, alternatively
conjugated Ub chains and the various Ub-like protein
modifications suggest these interactions are prevalent yet
poorly sampled [41,42]. Furthermore Ub/Ub-like PTMs
are proteins in their own right, therefore the storage of
thousands of covalent Ub modification events in inter-
action databases makes systematically dissecting genuine
Ub-modification dependent interactions difficult.
Conclusions
In general, systematic investigation linking specific
PTMs to large scale alterations in network structure have
lagged behind due to the technical challenges inherent in
connecting two large scale measurements,  that is, protein
interaction data and protein modification data. Combin-
ing recent MS studies and literature datasets, over
100,000 modifications across more than 12,000 unique
proteins have been identified in human cells. PTM data
sets are difficult to normalize and interpret because of
extensive enrichment protocols, incomplete sampling,
miscalls, large differences in protein abundance [61],
different PTM-occupancy levels [62] and relatively
low PTM-site conservation [63,64,65]. In addition
most PTMs may not function alone [64,65,66] yet
experimental strategies to tackle these dependencies are
just being developed [67]. However, upon changing
conditions, PTMs do show massive dynamic responses
with hundreds to thousand dynamic PTM-site changes
[62,68,69], providing a strong argument for their func-
tional importance. Predicting putative enzyme-site
relationships, for example, using an integrative Bayesian
approach [70], clustering dynamic changes throughout
the cell cycle [62] or in stem cell development [69], or
examining evolutionary conservation and structural
relationships [64,65] can all be informative in identi-
fying PTM functionality. However, as the MS studies
described above highlight [59,60], an additional
appropriate data filter for prioritizing the functionally
most relevant PTM-signals is interaction network con-
text. The first large MS study measuring lysine-acety-
lation reported that acetylation accumulates over protein
complexes in human cultured cells [71] and high phos-
phorylation  levels were observed on specific subunits of
mitotic complexes [72]. Supporting and extending this
idea, a first computational analysis of global acetylation,
phosphorylation and ubiquitylation data revealed that
modifications cluster within interaction networks [66].
Furthermore PTMi spots, short disordered amino acid
stretches with exceptional high PTM density, were
found in more than 400 human proteins and may be
important sites for PTM-mediated recognition events
[66]. These studies suggest that analysis of PTMswww.sciencedirect.com coupled to protein interaction information will promote
a better understanding of enzyme–substrate relation-
ships, the dynamics of PTM-mediated signal flow and
the consequences of PTM-mediated recognition events,
that is, the rewiring of molecular networks as a signaling
response. Function clusters within protein interaction
networks. Just as the interpretation of the large number
of genetic variation between genomes is greatly aided by
network information, evidence is piling up that protein–
protein interaction networks will be successfully
exploited in the analyses of the more than 100,000
cellular PTMs.
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